Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
11,776,439
-
Shares change
-
-1,589,226
-
Total reported value, excl. options
-
$38,392,556
-
Value change
-
-$5,167,507
-
Put/Call ratio
-
95%
-
Number of buys
-
26
-
Number of sells
-
37
-
Price
-
$3.26
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2022
As of 30 Sep 2022 Humacyte, Inc. - COM (HUMA) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,776,439 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., York Capital Management Global Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS OCONNOR LLC, Prescott General Partners LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, LPL Financial LLC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This table shows 89 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.